Soleno Therapeutics (SLNO) Invested Capital (2013 - 2014)
Soleno Therapeutics' (SLNO) quarterly Invested Capital came in at $101529.0 in Q4 2014, down 99.27% year-on-year from $14.0 million in Q4 2013, and down 99.27% on a QoQ basis from $14.0 million in Q4 2013.
Soleno Therapeutics (SLNO) Invested Capital (2013 - 2014) Analysis & Trends
Soleno Therapeutics (SLNO) has 2 years of Invested Capital data on file, last reported at $101529.0 in Q4 2014.
- On a quarterly basis, Invested Capital fell 99.27% year-over-year to $101529.0 in Q4 2014; TTM through Sep 2015 was $101529.0, a 99.27% decrease from a year earlier, with the FY2014 full-year figure at $101529.0, down 99.27% from the prior year.
- Invested Capital for Q4 2014 stood at $101529.0, down from $14.0 million in the prior quarter.
- Over the last five years, Invested Capital for SLNO reached as high as $14.0 million in Q4 2013 and fell as low as $101529.0 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 110.96 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 116.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | 101,529.00 |
| Dec 31, 2013 | 13.99 Mn |